KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Debt Ratio (2018 - 2022)

Historic Debt Ratio for TherapeuticsMD (TXMD) over the last 8 years, with Q3 2022 value amounting to 0.7.

  • TherapeuticsMD's Debt Ratio fell 2153.09% to 0.7 in Q3 2022 from the same period last year, while for Sep 2022 it was 0.7, marking a year-over-year decrease of 2153.09%. This contributed to the annual value of 1.11 for FY2021, which is 1512.2% down from last year.
  • According to the latest figures from Q3 2022, TherapeuticsMD's Debt Ratio is 0.7, which was down 2153.09% from 0.62 recorded in Q2 2022.
  • TherapeuticsMD's 5-year Debt Ratio high stood at 1.52 for Q1 2022, and its period low was 0.31 during Q3 2018.
  • For the 5-year period, TherapeuticsMD's Debt Ratio averaged around 0.81, with its median value being 0.78 (2019).
  • As far as peak fluctuations go, TherapeuticsMD's Debt Ratio soared by 15128.0% in 2019, and later tumbled by 3337.65% in 2021.
  • Quarter analysis of 5 years shows TherapeuticsMD's Debt Ratio stood at 0.35 in 2018, then surged by 111.39% to 0.73 in 2019, then soared by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then tumbled by 37.08% to 0.7 in 2022.
  • Its Debt Ratio stands at 0.7 for Q3 2022, versus 0.62 for Q2 2022 and 1.52 for Q1 2022.